WITH ERLEADA
®What is ERLEADA®?
ERLEADA® is a prescription medicine used to treat two types of prostate cancer:
Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone.
This is called metastatic castration-sensitive prostate cancer, or mCSPC.
OR
Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone.
This is called non-metastatic castration-resistant prostate cancer, or nmCRPC.
PSA LEVELS AND YOUR TREATMENT
If you have prostate cancer, you’re probably tracking your prostate-specific antigen (PSA) levels with your doctor.
See how data from this clinical study may impact your treatment plan.